Kalaris Therapeutics, Inc.

KLRS · XNAS

CIK 1754068fmd_1VE18HN42S6FJJ79CCZ1J8KC88Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 31 periods

Ratios computed from the standardized statements. Select a value to open its proof.